Wellcome Leap Psilocybin for OUD

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

October 31, 2027

Conditions

Opioid Use Disorder

Interventions

DRUG

Psilocybin

PEX010 is the Psilocybin produced by Filament

Trial Locations (1)

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors

lead

Anna Rose Childress, Ph.D.

OTHER

NCT06786325 - Wellcome Leap Psilocybin for OUD | Biotech Hunter | Biotech Hunter